Kitty
Senior Member (Voting Rights)
What efforts should we be making to tbat end?
It depends how it unfolds, I guess, but one of the things we could think about is anticipating replication trials carried out by teams who might assume they can lift methodologies over from other diseases. But of course inclusion of severe patients is a lot more complicated than usual, and mild/moderate ME/CFS is variable enough that pre-trial monitoring of participants and long term follow-up is essential, otherwise you can't show whether anything has changed.